|
1
|
Awad AJ, Burns TC, Zhang Y and Abounader
R: Targeting MET for glioma therapy. Neurosurg Focus. 37:E102014.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Katsetos CD, Reginato MJ, Baas PW,
D'Agostino L, Legido A, Ski Tuszyn JA, Dráberová E and Dráber P:
Emerging microtubule targets in glioma therapy. Semin Pediatr
Neurol. 22:49–72. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Klein M: Treatment options and
neurocognitive outcome in patients with diffuse low-grade glioma. J
Neurosurg Sci. 59:383–392. 2015.PubMed/NCBI
|
|
4
|
Kang JH and Adamson C: Novel
chemotherapeutics and other therapies for treating high-grade
glioma. Expert Opin Investig Drugs. 24:1361–1379. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Brandner S and von Deimling A: Diagnostic,
prognostic and predictive relevance of molecular markers in
gliomas. Neuropathol Appl Neurobiol. 41:694–720. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wang BC and Ma J: Role of microRNAs in
malignant glioma. Chin Med J (Engl). 128:1238–1244. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Garzon R, Calin GA and Croce CM: MicroRNAs
in cancer. Annu Rev Med. 60:167–179. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Thomas M, Lange-Grünweller K, Weirauch U,
Gutsch D, Aigner A, Grünweller A and Hartmann RK: The
proto-oncogene Pim-1 is a target of miR-33a. Oncogene. 31:918–928.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Yang L, Yang J, Li J, Shen X, Le Y, Zhou
C, Wang S, Zhang S, Xu D and Gong Z: MircoRNA-33a inhibits
epithelial-to-mesenchymal transition and metastasis and could be a
prognostic marker in non-small cell lung cancer. Sci Rep.
5:136772015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Du M, Zhang Y, Mao Y, Mou J, Zhao J, Xue
Q, Wang D, Huang J, Gao S and Gao Y: miR-33a suppresses
proliferation of NSCLC cells via targeting METTL3 mRNA. Biochem
Biophys Res Commun. 482:582–589. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhang M, Gong W, Zuo B, Chu B, Tang Z,
Zhang Y, Yang Y, Zhou D, Weng M, Qin Y, et al: The microRNA miR-33a
suppresses IL-6-induced tumor progression by binding Twist in
gallbladder cancer. Oncotarget. 7:78640–78652. 2016.PubMed/NCBI
|
|
12
|
Han SY, Han HB, Tian XY, Sun H, Xue D,
Zhao C, Jiang ST, He XR, Zheng WX, Wang J, et al: MicroRNA-33a-3p
suppresses cell migration and invasion by directly targeting PBX3
in human hepatocellular carcinoma. Oncotarget. 7:42461–42473.
2016.PubMed/NCBI
|
|
13
|
Zhang C, Zhang Y, Ding W, Lin Y, Huang Z
and Luo Q: miR-33a suppresses breast cancer cell proliferation and
metastasis by targeting ADAM9 and ROS1. Protein Cell. 6:881–889.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhou J, Xu D, Xie H, Tang J, Liu R, Li J,
Wang S, Chen X, Su J, Zhou X, et al: miR-33a functions as a tumor
suppressor in melanoma by targeting HIF-1α. Cancer Biol Ther.
16:846–855. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wolfe AR, Bambhroliya A, Reddy JP, Debeb
BG, Huo L, Larson R, Li L, Ueno NT and Woodward WA: miR-33a
decreases high-density lipoprotein-induced radiation sensitivity in
breast cancer. Int J Radiat Oncol Biol Phys. 95:791–799. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Liang C, Yu XJ, Guo XZ, Sun MH, Wang Z,
Song Y, Ni QX, Li HY, Mukaida N and Li YY: MicroRNA-33a-mediated
downregulation of Pim-3 kinase expression renders human pancreatic
cancer cells sensitivity to gemcitabine. Oncotarget. 6:14440–14455.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Li Q, Lu S, Li X, Hou G, Yan L, Zhang W
and Qiao B: Biological function and mechanism of miR-33a in
prostate cancer survival and metastasis: via downregulating
Engrailed-2. Clin Transl Oncol. 19:562–570. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhou Y, Huang Z, Wu S, Zang X, Liu M and
Shi J: miR-33a is up-regulated in chemoresistant osteosarcoma and
promotes osteosarcoma cell resistance to cisplatin by
down-regulating TWIST. J Exp Clin Cancer Res. 33:122014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wang H, Sun T, Hu J, Zhang R, Rao Y, Wang
S, Chen R, McLendon RE, Friedman AH, Keir ST, et al: miR-33a
promotes glioma-initiating cell self-renewal via PKA and NOTCH
pathways. J Clin Invest. 124:4489–4502. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Shao J, Yang X, Liu T, Zhang T, Xie QR and
Xia W: Autophagy induction by SIRT6 is involved in oxidative
stress-induced neuronal damage. Protein Cell. 7:281–290. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Song J, Ke SF, Zhou CC, Zhang SL, Guan YF,
Xu TY, Sheng CQ, Wang P and Miao CY: Nicotinamide
phosphoribosyltransferase is required for the calorie
restriction-mediated improvements in oxidative stress,
mitochondrial biogenesis, and metabolic adaptation. J Gerontol A
Biol Sci Med Sci. 69:44–57. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Jeong CH and Joo SH: Downregulation of
reactive oxygen species in apoptosis. J Cancer Prev. 21:13–20.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Feng J, Yan PF, Zhao HY, Zhang FC, Zhao WH
and Feng M: SIRT6 suppresses glioma cell growth via induction of
apoptosis, inhibition of oxidative stress and suppression of
JAK2/STAT3 signaling pathway activation. Oncol Rep. 35:1395–1402.
2016.PubMed/NCBI
|
|
24
|
Jansson MD and Lund AH: MicroRNA and
cancer. Mol Oncol. 6:590–610. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Nugent M: microRNA and Bone Cancer. Adv
Exp Med Biol. 889:201–230. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kuo PL, Liao SH, Hung JY, Huang MS and Hsu
YL: MicroRNA-33a functions as a bone metastasis suppressor in lung
cancer by targeting parathyroid hormone related protein. Biochim
Biophys Acta. 1830:3756–3766. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kugel S, Sebastián C, Fitamant J, Ross KN,
Saha SK, Jain E, Gladden A, Arora KS, Kato Y, Rivera MN, et al:
SIRT6 suppresses pancreatic cancer through control of Lin28b. Cell.
165:1401–1415. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Elhanati S, Ben-Hamo R, Kanfi Y, Varvak A,
Glazz R, Lerrer B, Efroni S and Cohen HY: Reciprocal regulation
between SIRT6 and miR-122 controls liver metabolism and predicts
hepatocarcinoma prognosis. Cell Reports. 14:234–242. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Dávalos A, Goedeke L, Smibert P, Ramírez
CM, Warrier NP, Andreo U, Cirera-Salinas D, Rayner K, Suresh U,
Pastor-Pareja JC, et al: miR-33a/b contribute to the regulation of
fatty acid metabolism and insulin signaling. Proc Natl Acad Sci
USA. 108:9232–9237. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Lee N, Ryu HG, Kwon JH, Kim DK, Kim SR,
Wang HJ, Kim KT and Choi KY: SIRT6 depletion suppresses tumor
growth by promoting cellular senescence induced by DNA damage in
HCC. PLoS One. 11:e01658352016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Bai L, Lin G, Sun L, Liu Y, Huang X, Cao
C, Guo Y and Xie C: Upregulation of SIRT6 predicts poor prognosis
and promotes metastasis of non-small cell lung cancer via the
ERK1/2/MMP9 pathway. Oncotarget. 7:40377–40386. 2016.PubMed/NCBI
|
